Regentatlantic Capital Has Trimmed United Therapeutics Del (UTHR) Holding By $423024; NUTRAFUELS (NTFU …
<!–
Market News
–>
July 15, 2018 – By Mary Kidd
NUTRAFUELS INC (OTCMKTS:NTFU) had a decrease of 37.5% in short interest. NTFU’s SI was 2,500 shares in July as released by FINRA. Its down 37.5% from 4,000 shares previously. The SI to NUTRAFUELS INC’s float is 0.01%. The stock increased 5.00% or $0.01 during the last trading session, reaching $0.21. About 19,490 shares traded. NutraFuels, Inc. (OTCMKTS:NTFU) has 0.00% since July 15, 2017 and is . It has underperformed by 12.57% the SP500.
Regentatlantic Capital Llc decreased United Therapeutics Corp Del (UTHR) stake by 30.94% reported in 2018Q1 SEC filing. Regentatlantic Capital Llc sold 3,777 shares as United Therapeutics Corp Del (UTHR)’s stock declined 10.66%. The Regentatlantic Capital Llc holds 8,432 shares with $947,000 value, down from 12,209 last quarter. United Therapeutics Corp Del now has $5.43B valuation. The stock increased 0.48% or $0.6 during the last trading session, reaching $124.74. About 125,357 shares traded. United Therapeutics Corporation (NASDAQ:UTHR) has declined 12.46% since July 15, 2017 and is downtrending. It has underperformed by 25.03% the SP500. Some Historical UTHR News: 02/05/2018 – Analytic Investors LLC Exits Position in United Therapeutics; 02/05/2018 – United Therapeutics 1Q Adj EPS $3.76; 02/05/2018 – UNITED THERAPEUTICS 1Q ADJ. EPS 3.76, EST. $3.56; 30/04/2018 – United Therapeutics: Milestone Related to Commercialization of Trevyent; 26/03/2018 Roger Jeffs, Former Co-CEO of United Therapeutics, Joins Pluristem’s Strategic Advisory Board; 30/04/2018 – UNITED THERAPEUTICS: DEAL VALUED AT $216M; 30/04/2018 – United Therapeutics to Buy SteadyMed — Deal Digest; 30/04/2018 – United Therapeutics to Buy SteadyMed for $4.46/Share Cash at Closing; 30/04/2018 – United Therapeutics To Acquire SteadyMed Ltd. STDY; 02/05/2018 – United Therapeutics 1Q Net $244.5M
NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products to retail and wholesale outlets. The company has market cap of $17.92 million. The companyÂ’s products include sleep spray to support a healthy sleep cycle and improve the quality of restful sleep; energize spray to enhance energy, and restore vigor and vitality; and garcinia cambogia spray, an appetite and weight management spray. It currently has negative earnings. It also offers NRG-X extreme energy spray to enhance energy and stamina; headache and pain spray to relieve headaches and pain; and hair, skin, and nails spray to nourish and encourage hair, skin, and nail growth.
Since March 14, 2018, it had 0 insider buys, and 12 selling transactions for $27.22 million activity. ROTHBLATT MARTINE A had sold 21,512 shares worth $2.42 million. Olian Judy D. had sold 600 shares worth $67,425. Another trade for 3,240 shares valued at $366,353 was sold by DWEK RAYMOND.
Among 3 analysts covering United Therapeutics (NASDAQ:UTHR), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. United Therapeutics had 9 analyst reports since January 19, 2018 according to SRatingsIntel. The stock of United Therapeutics Corporation (NASDAQ:UTHR) has “Underperform” rating given on Thursday, February 22 by Credit Suisse. The stock of United Therapeutics Corporation (NASDAQ:UTHR) earned “Neutral” rating by Credit Suisse on Tuesday, April 3. Credit Suisse maintained the shares of UTHR in report on Thursday, May 3 with “Neutral” rating. The firm has “Underweight” rating by Barclays Capital given on Thursday, May 3. The stock has “Buy” rating by Wedbush on Friday, May 4. The firm earned “Neutral” rating on Tuesday, July 10 by Credit Suisse. Barclays Capital maintained the stock with “Underweight” rating in Thursday, February 22 report. As per Tuesday, February 27, the company rating was maintained by Wedbush.
Another recent and important United Therapeutics Corporation (NASDAQ:UTHR) news was published by Globenewswire.com which published an article titled: “Factors of Influence in 2018, Key Indicators and Opportunity within Dr Pepper Snapple Group, United Therapeutics …” on June 25, 2018.
Analysts await United Therapeutics Corporation (NASDAQ:UTHR) to report earnings on July, 26. They expect $2.57 earnings per share, up 305.60% or $3.82 from last year’s $-1.25 per share. UTHR’s profit will be $111.91M for 12.13 P/E if the $2.57 EPS becomes a reality. After $5.57 actual earnings per share reported by United Therapeutics Corporation for the previous quarter, Wall Street now forecasts -53.86% negative EPS growth.
Regentatlantic Capital Llc increased Jpmorgan Chase Co (AMJ) stake by 82,677 shares to 1.45M valued at $34.89 million in 2018Q1. It also upped Dxc Technology Co stake by 42,754 shares and now owns 94,047 shares. Vanguard Index Fds (VOO) was raised too.
Investors sentiment decreased to 0.87 in Q1 2018. Its down 0.27, from 1.14 in 2017Q4. It fall, as 33 investors sold UTHR shares while 124 reduced holdings. 41 funds opened positions while 96 raised stakes. 40.96 million shares or 0.16% more from 40.90 million shares in 2017Q4 were reported. Advisory Svcs Network Lc accumulated 100 shares. Archford Cap Strategies Limited Liability Corp has 6 shares. Old Bancshares In holds 0.02% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 3,434 shares. Strategic Advsrs Ltd Llc has 0.38% invested in United Therapeutics Corporation (NASDAQ:UTHR) for 9,990 shares. Pictet Asset Management holds 0.03% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 111,139 shares. Wellington Grp Inc Llp reported 9,375 shares stake. Moreover, Korea Invest Corp has 0.03% invested in United Therapeutics Corporation (NASDAQ:UTHR) for 64,056 shares. South Dakota Investment Council reported 0.13% stake. Brown Advisory, Maryland-based fund reported 3,000 shares. Retirement Of Alabama invested in 0.03% or 55,923 shares. Apg Asset Mgmt Nv has 0.12% invested in United Therapeutics Corporation (NASDAQ:UTHR). Caisse De Depot Et Placement Du Quebec has 0% invested in United Therapeutics Corporation (NASDAQ:UTHR). Convergence Investment Prtnrs holds 0% or 149 shares in its portfolio. California State Teachers Retirement System stated it has 0.02% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Liberty Mutual Group Asset Mgmt invested 0.03% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR).
Receive News Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.